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ReviewThe Unfolding Story of
Three-Dimensional Domain Swapping
physiological significance of these highly intertwined
oligomers remains unclear. Also, experimental data on
the thermodynamics and the mechanism of domain
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Meyerhofstrasse 1 swapping were, until very recently, almost only qualita-
tive. In part, this was due to problems inherent in the69117 Heidelberg
Germany experimental study of domain swapping. First, domain-
swapped oligomeric forms are often metastable; once2 Cambridge University Chemical Laboratory
MRC Centre for Protein Engineering formed, they take a long time to convert back to the more
stable monomeric form and therefore any quantitativeLensfield Road
Cambridge, CB2 1EW analysis, for example the measurement of equilibrium
constants, becomes unfeasible. Second, tractable modelUnited Kingdom
systems are required, ones in which both monomer and
domain-swapped forms can be isolated and studied
easily in solution. In the last couple of years, these prob-Summary
lems have been overcome and much has subsequently
been revealed to explain domain swapping [5], in partic-Three-dimensional domain swapping is the event by
which a monomer exchanges part of its structure with ular by the combined use of protein engineering and the
biophysical tools that have been applied so successfullyidentical monomers to form an oligomer where each
subunit has a similar structure to the monomer. The to investigate protein folding. As researchers become
increasingly interested in understanding and quantifyingaccumulating number of observations of this phenom-
enon in crystal structures has prompted speculation protein aggregation, mechanisms of self-association
such as domain swapping have become the focus ofas to its biological relevance. Domain swapping was
originally proposed to be a mechanism for the emer- attention and in the future will continue to provide new
insights into the process.gence of oligomeric proteins and as a means for func-
tional regulation, but also to be a potentially harmful
process leading to misfolding and aggregation. We Domain Swapping: Definition and Terminology
highlight experimental studies carried out within the Domain swapping is defined as the process by which
last few years that have led to a much greater under- two or more protein molecules exchange part of their
standing of the mechanism of domain swapping and structure to form intertwined oligomers. These oligo-
of the residue- and structure-specific features that mers are composed of subunits having the same struc-
facilitate the process. We discuss the potential biologi- ture as the original monomer, with the exception of the
cal implications of domain swapping in light of these hinge loop that connects the exchanging part with the
findings. rest of the structure and which is usually folded back
on itself in the monomer and extended in the domain-
Background swapped oligomer [1, 2]. The term “domain” is not used
Three-dimensional domain swapping is a process by in a strict sense, as proteins have been reported to swap
which one protein molecule exchanges a domain with entire tertiary globular domains [2, 6] but also often only
an identical partner (Figures 1A and 1B). Although it had a single element of secondary structure, such as an 
been proposed as the mechanism for the formation of helix [7, 8] or a single strand of  sheet [9]. Although
RNase A dimers as far back as 1962, domain swapping initially only domain-swapped dimers were observed,
was first observed in crystal structures during the eight- barnase was later shown to be able to fold into a domain-
ies and nineties, and the terminology was only formally swapped trimer [10]. The exchanging part of the struc-
introduced by Eisenberg and coworkers in 1994 to de- ture makes the same interactions in the oligomer as it
scribe the crystal structure of diphtheria toxin [1, 2]. This makes in the monomer, but its interactions are formed
structure led to a series of elegant theoretical papers inter- rather than intramolecularly. These interactions
by Eisenberg and coworkers that proposed how and that are identical in the monomer and oligomer form
why domain swapping might occur and the potential the “primary” interface [11]. Because subunits are often
biological implications. The latter included domain close to each other in a domain-swapped oligomer, a
swapping as a mechanism for regulating function, as new interaction interface that is absent in the monomer
an evolutionary strategy to create protein complexes, may be formed, and this is termed the “secondary” inter-
and as a mechanism for misfolding and aggregation face (Figure 1A) [11].
(Figure 1C) [1, 2].
More than 30 crystal structures of domain-swapped
Biological Relevance of Domain Swapping:molecules have been elucidated since [3, 4], but the
Hypotheses and Experimental Evidence
Almost 10 years after the identification of domain swap-
*Correspondence: lsi10@cam.ac.uk (L.S.I.), schymkow@embl.de
ping, popular model proteins such as chymotrypsin(J.W.H.S.)
inhibitor 2 (CI2) [12], barnase [10], SH3 [13], and staphy-3 Present address: Hutchison/MRC Centre, Hills Road, Cambridge,
CB2 2XZ, United Kingdom. lococcal nuclease [8] have now crystallized in domain-
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Figure 1. Basic Principles in Domain Swapping
(A) Simplified representation of a monomer
and a domain-swapped dimer, with the sec-
ondary surface highlighted in red (see text).
(B) Schematic representation of structures of
a monomer [70] and domain-swapped dimer
[9, 54] of suc1 obtained using the program
MOLSCRIPT [71]. The domain-swapping
C-terminal  strand and the hinge loop are
shown in red.
(C) Schematic representation of open-ended
and closed-ended domain-swapped oligomers.
swapped forms, as have many others. There is no appar- binding protein OBP [22], the DNA recombination and
repair protein from E. coli RecA [23], citrate synthaseent structural or functional connection between these
different proteins and examples are appearing across from chicken heart [24], and many more proteins car-
rying out diverse functions. However, clear evidence fororganisms and structural and functional classifications.
A more complete overview can be found elsewhere [3, a functional role of domain swapping is lacking and, as
all these structures have been observed in crystal forms,4], while below a few examples are presented to illus-
trate the diversity of domain swapping (see also Fig- they could easily be suspected to be an artifact of the
nonphysiological conditions and high protein concen-ure 2).
Both SH2 and SH3 domains, probably the most stud- trations used for crystallization. Several hypotheses to-
gether with coincident lines of evidence neverthelessied protein-protein interaction domains in signal trans-
duction, have been reported to crystallize as domain- suggest a significance for domain swapping in vivo.
The first potential biological role for domain swappingswapped dimers [13, 14]. The dimeric form of bovine
seminal RNase was the first RNase found to domain is the functional regulation of proteins. Here several in-
teresting observations have been made. Glyoxalase Iswap [15], but later the bacterial RNase barnase was
reported to form domain-swapped trimers [10], and bo- from Pseudomonas was shown to exist both in an active
domain-swapped dimeric state and as a metastable andvine RNase A was recently shown to swap two different
structural elements [7, 16, 17]. The first of these is less active monomer. In vitro conversion from dimeric
to metastable monomeric glyoxalase I can be triggeredformed by swapping an N-terminal  helix and the sec-
ond by swapping a C-terminal  strand. Other examples upon addition of glutathione [25, 26]. After removal of
glutathione, glyoxalase I slowly reverts to a more stableinclude a coat protein from Simian virus 40 [18], the lens
eye protein B2-crystallin [19], the cell cycle regulatory and active domain-swapped form. Although no evi-
dence exists for such a mechanism in vivo, this demon-proteins from the cks family [9, 20, 21], bovine odorant
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Figure 2. Schematic Representations of Do-
main-Swapped Proteins
(A) Bovine seminal ribonuclease (PDB ID
code 11bg) [27].
(B) Suc1 (PDB ID code 1sce) [9, 54].
(C) Bovine odorant binding protein (PDB ID
code 1g85) [72].
(D) Recombination endonuclease VII from
[73] (PDB ID code 1e7d).
(E) Rice yellow mottle virus coat protein (PDB
ID code 1f2n) [29].
This figure was generated using PyMOL
(http://www.pymol.org).
strates that functional regulation by domain swapping amyloidogenic human cystatin C [40, 41] in domain-
swapped forms. Fourth, Eisenberg and coworkers werecan, in principle, be achieved. Another interesting find-
ing is that formation of domain-swapped oligomers can able to design both domain-swapped dimers and high-
order oligomers from the same three-helix bundle struc-introduce allosteric regulation of the protein activity al-
ready present in the monomer, as shown in bovine semi- tural motif but with different topologies [7, 16, 17]. An up-
down-down favored a reciprocal swap to form a closednal RNase [27]. Also, several receptor proteins, including
G-coupled receptors, are thought to dimerize by domain domain-swapped dimer. An up-down-up topology was
predicted to favor an extended swap, and fibrils wereswapping [28]. Finally, the viral capsid of an icosahedral
virus that was recently found to be composed of do- formed that were assumed to be domain swapped.
Finally, domain swapping has been proposed to con-main-swapped dimers has higher thermostability than
other viruses from the same family lacking the domain- tribute to structural diversification and the emergence of
oligomers during evolution [11], but here again, althoughswapped architecture [28, 29].
A second proposed biological implication of domain the idea is elegant and simple, it is not clear what the
relevance of this is in vivo. Interestingly, it was recentlyswapping is a detrimental one. Domain swapping has
the potential to be a mechanism for protein misfolding, shown that core mutations could introduce oligomeriza-
tion by domain swapping, with the formation of a newaggregation, and amyloid formation (Figure 1C) [11, 30,
31] and thus it may be related to misfolding leading to hydrophobic interface and structural rearrangement of
other parts of the protein [42].amyloid and prion diseases [11, 17, 30, 32–34]. Here
again, direct evidence for domain swapping as a mecha-
nism for aggregation and amyloid formation is lacking, Energetic Contributions to Domain Swapping
A quantitative understanding is needed, first of the fac-but several observations strongly suggest that it might
indeed be the case. First, transient aggregation ob- tors that can contribute to the equilibrium between a
monomer and its oligomeric alter ego, and second ofserved during refolding of several proteins has been
suggested to occur by domain swapping [35–38]. Sec- how interconversion between the two forms occurs.
Oligomers are always disfavored by their greater transla-ond, a correlation between domain swapping propensity
and the rate of heat aggregation of suc1 was observed tional and rotational entropy [11]. Further, domain-
swapped oligomers are made up of subunits that are[5]. Third, a role for domain swapping in the processes
of prion and amyloid formation is suggested by the crys- identical in structure to the monomer, except for (1) the
hinge loop and (2) the secondary interface [11]. Thesetallization of both the human prion protein [39] and the
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more favorable extended conformation of the shortenedTable 1. Dissociation Constants for Suc1 Wild-Type and
hinge loop in the domain-swapped form. Loop lengthen-Mutants in the Hinge Loop
ing also has an effect on the oligomerization state of
Mutation Kd (mM) proteins. Monomeric CI2 forms domain-swapped di-
Wild-type 1.9 mers, as well as trimers and even higher order oligomers,
P90A 890 when its active site loop is lengthened by 5–10 residues
P92A 0.2 [12]. Moreover, the presence of high-order oligomeric
E91P 0.0001
forms increases with loop insertions consisting of re-P90AP92A 11.2
peats of Gln→Ala→Gly. The same observation was8789 1  106
made in suc1: wild-type suc1 only forms monomers and
Values were taken from [5, 53].
domain-swapped dimers at protein concentrations in
the low millimolar range. However, when both prolines
of its hinge loop are mutated to alanine, trimers and
conformational differences can either favor or disfavor tetramers are observed, even more so when both pro-
domain swapping and will greatly determine the equilib- lines are substituted by glycines (F.R., J.W.H.S., and
rium between monomer and domain-swapped forms. L.S.I., unpublished results). Thus, making the hinge loop
A convenient way to quantify the monomer-dimer more flexible, either by lengthening it or by mutation,
equilibrium is by using the dissociation constant Kd, also induces swapping. There is a kinetic, as well as a
defined as thermodynamic component of the effect of loop length-
ening, discussed later in the review.




domain swapping propensity? Bergdoll and coworkers
observed that prolines are frequently found in the hingewhere [M] is the monomer concentration and [D] is the
loops of proteins that domain swap by arm exchangedimer concentration in monomeric units. The Kd can be
[47], and most recently the TorD chaperone was foundseen as the protein concentration at which half of the
as a domain-swapped dimer with a double-proline motifprotein molecules are dimeric. The free energy differ-
in its hinge [48]. Experiments on suc1 suggest a thermo-ence associated with this equilibrium can be obtained
dynamic explanation. Suc1, which can fold as a mono-from
mer or an intertwined dimer with a Kd of 1.8 mM, has
two prolines in its hinge loop [49]. Mutation of eitherG  RT ln Kd (2)
proline to alanine dramatically shifts the monomer-dimer
The Kd for dimerization has been measured for a handful equilibrium, while mutation to alanine of any other resi-
of domain-swapped dimers, and Table 1 shows the val- due in the hinge loop has very little effect [5] (see Table
ues for the protein suc1 and a subset of mutants. The 2). Pro90 is unfavorable in the monomer hinge conforma-
Kd’s for the natural proteins measured to date are in the tion; the mutation Pro90Ala shifts the equilibrium com-
micromolar and millimolar range, which is far above the pletely toward the monomer. Pro92, on the other hand,
nanomolar range that would be expected for a biologi- is unfavorable in the dimer; the mutation Pro92Ala shifts
cally relevant process. However, the energy required to the equilibrium toward the dimer and has a Kd of 100
tip the balance is not large, considering that the entropic M (Table 1). Thus, the hinge loop in both monomer and
cost of fixing two molecules into a dimer is probably on dimer forms of the protein is in a “strained” conforma-
the order of a few kilocalories [43]. From Equation 2, a tion, more so in the monomer. The strain causes the
free energy change of approximately 4 kcal mol1 results hinge loop to act like a loaded molecular spring that
in a change in the dissociation constant of three orders relieves the tension by adopting an alternative confor-
of magnitude. Thus, a few mutations in the hinge loop mation without altering the rest of the structure. In the
or in the secondary interface, designed to favor the case of suc1, the destabilization of the hinge loop by
dimer, could easily bring the Kd into the nanomolar the prolines does not appear to arise from unfavorable
range. This is illustrated in Table 1 for suc1, and the interactions with other residues but rather from back-
effects of the different mutations are explained below. bone strain that the prolines impose on each other as
a double mutant cycle (Pro90AlaPro92Ala) demon-
The Hinge Loop and the Domain strated [5, 49]. We were able to engineer mutants with
Swapping Propensity domain swapping propensities spanning nine orders of
What are the specific sequence and structural require- magnitude, by manipulating the strain in the hinge loop
ments that turn a protein segment (generally a loop) into conformation of suc1 (Figure 3; Table 1) [5]. The principle
a hinge loop that facilitates domain swapping? Some that unfavorable interactions turn hinge loops into
early experiments addressed this question by focusing loaded springs also appears to be generally applicable.
on the length of the hinge loop. Shortening the hinge In protein L [50, 51], for instance, the monomeric hinge
loop in staphylococcal nuclease [8], suc1 [5], ckshs1 loop was destabilized by forcing residues into forbidden
[44], CD2 [45], and single-chain Fv [46] destabilizes regions of the Ramachandran plot, thereby inducing an
these monomeric proteins by making the hinge loop alternate, domain-swapped form.
too tight to close the monomeric conformation. This In conclusion, domain swapping ability can be intro-
is sufficient to induce formation of domain-swapped duced into a protein by manipulating loops in one of
dimers in these proteins. Here, the entropic cost of asso- two ways. The first is by destabilizing the conformation
of a loop in the monomer, either by shortening it orciation is more than compensated by the energetically
Review
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Table 2. Design Approaches for Domain Swapping
Protein Description
Hinge Shortening
Staphylococcal nuclease [8] Deletion of 6 residues from hinge loop
Suc1 [5] Deletion of 3 residues from hinge loop
CD2 [45] Deletion of 2 residues from hinge loop
Single-chain Fv antibody [74] Length of linker between variable domains controls oligomerization state. Short linkers (2–10 residues)
lead to oligomer formation; longer linkers (12–25 residues) lead to stable monomeric forms.
Introduction of Strain in Hinge by Amino Acid Substitution
Suc1 [5] Mutation of glutamate 91 in the hinge loop to proline
Ckshs1 [44] Mutation of glutamate 63 in the hinge loop to proline
Protein L [50] Mutations in the hinge loop A52V, N53P, and G55A
Cyanovirin-N [75] Mutation of serine 52 to proline in hinge loop
Hinge Lengthening
CI2 [12] Insertion of glutamine repeat in hinge loop
Introduction of Flexibility in Hinge
Suc1 [5] Mutation of prolines 90 and 92 to glycine in hinge loop
Other Mutations
CD2 [45] Mutation of residues in the intermolecular interface
GB1 [42] Mutation of residues in the hydrophobic core
These mutational strategies were used to successfully convert monomeric proteins into obligate dimers. For terminology, see text.
by introducing unfavorable interactions. This forces the form. These interactions contribute to the domain swap-
ping propensity by stabilizing the dimer [46, 52]. Suc1loop into a more favorable conformation in a domain-
swapped variant of the original monomeric structure. has no secondary interface, and therefore the equilib-
rium between monomer and dimer is solely determinedBecause “spring loading” applies to rather short and
inflexible loops, the propensity for domain swapping by the hinge loop. In spite of this, mutations to alanine
elsewhere in the protein were not neutral in their effectachieved in this way is high and is biased toward a
specific oligomeric state. The second way to facilitate on the equilibrium between monomer and dimer. Al-
though the effects were not as large as for mutation indomain swapping is by inserting a long and/or flexible
loop into the monomeric structure. Here the propensity the hinge loop, they were significant (changes in Kd of
one to two orders of magnitude) [53]. Specifically, muta-to domain swap is generally lower than that achieved
using the first approach, and also less specific because tions to alanine in the  sheet shifted the equilibrium
toward the monomer, showing that those interactionsthe flexibility of the loop allows it to adopt many confor-
mations with similar energy. There is a kinetic compo- are more favorable in the dimer. Further, a phospho-
protein binding site of suc1 in the sheet on the oppositenent to these effects, as discussed later.
side of the molecule to the hinge loop and at a distance
of more than 20 A˚, has a different affinity for phospho-Contribution of Residues Outside the Hinge
to Domain Swapping Propensity substrates in the monomer compared with the dimer
[53]. The crystal structures of the monomer and domain-How do these changes in domain swapping propensity
compare to those that occur upon mutation elsewhere swapped dimer are highly superimposable outside of
the hinge loop region, so that there is no obvious struc-in the protein? Mutagenesis studies of CD2 were fo-
cused on the secondary interface—the new intermolec- tural reason for these effects. The different response to
mutation of the two forms of the protein appears toular interface that is created in the domain-swapped
Figure 3. Scheme Showing the Conse-
quences of Backbone Strain Created by Pro-
line Residues
The hinge residues are represented as color-
coded bricks. Prolines are shown in dark blue
and their preceding peptide bond is in bold
to indicate the restrictions that are imposed
on it by the ring of the proline. Positions of
backbone strain are shown by yellow zigzag
lines. There is an equilibrium in the wild-type
protein between the monomer conformation
in which P90 is strained and the dimer confor-
mation in which P92 is strained [5].
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originate in the hinge loop. The conformation of the man homolog of suc1, ckshs1, unfolds much faster than
suc1, and the monomer-dimer interconversion is alsohinge loop is more strained in the monomer than in the
dimer [5], and the strain is sensed throughout the  much faster compared with suc1 [45]. These data led
to a model in which a suc1 molecule can fold eithersheet. As a result, the  sheet is somewhat less satisfied
when accompanied by the  turn hinge in the monomer as a monomer or a domain-swapped dimer from the
denatured state [5]. Interconversion has to proceed viaconformation than with the extended hinge conforma-
tion in the dimer [53]. Indeed, removing the strain in the the denatured state and the kinetic barrier between mo-
nomer and dimer under native conditions is a directhinge loop by mutating both prolines to alanine reduces
the difference in energetic behavior of the two forms. consequence of the coupling of two folding reactions in
the denatured state. In a kinetic study of an engineeredThe biological implications of these observations are
discussed later. In conclusion, however, the presence domain-swapped dimer of the N-terminal domain of
CD2, in which an antiparallel  sheet is formed intermo-of an unfavorable loop conformation in a protein does
not only promote domain swapping, but also subtly af- lecularly, the authors reach a similar conclusion that
association occurs in the denatured state and foldingfects the energetics of the entire structure, probably by
altering its dynamic behavior. of the intertwined dimer is a subsequent step [52].
To conclude, the mechanism of converting a mono-
meric protein into a domain-swapped oligomer is highly
An Unfolding Mechanism for Domain Swapping dependent on the folding mechanism of the particular
Domain swapping is essentially a protein-folding phe- protein. The more independent the structure of the
nomenon, as it gives a single polypeptide sequence swapping elements and the more framework-like the
access to two or more well-defined native states. Two folding mechanism, the later during folding they can
questions immediately arise. First, what are the folding associate. In many cases, however, the swapped ele-
pathways to monomer and domain-swapped oligomer ments are highly intertwined and not independently sta-
and how are they connected to each other? Second, ble, and the folding is a very concerted process; conse-
can one control which state is produced upon refolding quently, association will occur before too much of the
of a domain-swapping protein? structure is present.
Generally, interconversion between monomer and di-
mer is very slow (from days to months) [5, 11], and thus Domain Swapping, Refolding, and Aggregation
both states are separated by a large kinetic barrier. For A protein engineering analysis of the folding pathways
interconversion to occur, many native interactions, often of both the monomer and the dimer forms of suc1 re-
in the hydrophobic core, must be disrupted, to be re- vealed that the two folding processes are controlled by
placed by identical interactions with another protein the same key interactions (or folding nucleus) [55, 56].
chain. Eisenberg and coworkers proposed that the tran- As a consequence, there is ambiguity in the refolding
sition state for interconversion is an “open” form of the of suc1: either the interactions between the  strands
structure, disrupting many native interactions while are made intramolecularly and the monomer is formed,
maintaining the overall native fold of the exchanging or two chains associate with the interactions between
domains, which is both enthalpically and entropically the  strands occurring intermolecularly and the do-
unfavorable [11]. Such a scenario is most likely for cases main-swapped dimer is formed. The competition be-
that involve the swapping of true domains that can fold tween the collapse of a chain on itself to form a monomer
independently of each other and then associate. How- and the probability of interacting with another chain
ever, several domain-swapped structures may require before the key interactions are formed explains the ef-
a more intricate interplay between folding and associa- fect of loop length on domain swapping. Loop lengthen-
tion. In the case of barnase [10], for example, the parts ing slows down the rate of folding of the monomer be-
of the structure that swap can only fold partially in an cause of the higher entropic cost of fixing a longer loop
independent manner. The authors of the domain- rather than a shorter one [58, 59], and this indirectly
swapped barnase structure therefore proposed that as- favors folding to the dimer because it increases the
sociation must occur at the latest at an intermediate likelihood of association with another chain [58]. Loop
stage of folding. lengthening thus promotes domain swapping by making
The situation is even more extreme in the case of suc1 it kinetically more accessible.
and its homologs, where a  strand that is a central Another consequence of increasing loop length or
part of the hydrophobic core is exchanged to form the flexibility is the increased tendency to aggregate, as
domain-swapped dimer [9, 20, 54]. A protein engineering observed in suc1 and other proteins. And it is only one
analysis of the folding mechanism of both monomeric step further to suggest that protein aggregation could
[55] and dimeric [56] suc1, complemented by molecular likewise occur using the same “native” nucleus but by
dynamics simulations of unfolding of the monomer [57], swapping in an open-ended manner to form an extended
shows that the interactions that connect this  strand chain. Indeed, several studies have illustrated the close
to the rest of the protein are formed very early in the relationship between aggregation and the monomeric
folding reaction and thus that their disruption requires folding reaction of proteins. Transient aggregation was
substantial unfolding. Further, the time required for mo- observed during the refolding of suc1 as well as CI2,
nomer-dimer equilibration in suc1 can be reduced from U1A [31, 35], and maltose binding protein [36], a dimeric
a few months to a few minutes simply by increasing the folding intermediate has been characterized in the fold-
unfolding rate significantly by changing the temperature, ing reaction of monomeric CheY [60], and a dimeric acid-
denatured state has been observed for barnase [61].denaturant concentration, or pH [5]. Likewise, the hu-
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Biological Implications of Domain Swapping: acterizes amyloid fibrils, domain swapping could play
a role in the early stages of fibril formation. Open-endedA Balance between Optimizing Function
and Minimizing Misfolding domain-swapped oligomers are alternative forms of the
protein that are folded but unstable because they haveAside from the regulatory switch that domain swapping
may provide in a small number of proteins, a more gen- unsatisfied surfaces at the termini. These species could
therefore act as precursors or intermediates in fibril for-eral, and negative, picture for the significance of domain
swapping in vivo is beginning to emerge. Loops play an mation. They could provide a reservoir of partly folded
or easily unfoldable molecules (see for example [66]),important role in the function of proteins, and are often
the location of binding sites or catalytic sites. The func- thereby giving rise to many nuclei for the formation of
the ultimate fibril state. Of particular interest also is thetional requirement for specific residues in specific orien-
tations in these sites often results in the introduction of yeast prion Ure2p, which retains its native -helical con-
formation in fibrils, in contrast to a cross- structure,unfavorable interactions. The strain imposed, in suc1
for example, can even provide the means to facilitate suggesting a mechanism for assembly similar to domain
swapping [67]. Domain swapping may also facilitatesignal transduction between remote parts of the struc-
ture. On the down side, however, the introduction of other polymerization processes such as the formation
of SNARE complexes in membrane fusion [68] and thestrain in loops can create a propensity to domain swap
and thereby cause misfolding and aggregation. With this assembly of pilus fibers [69].
in mind, apparently neutral mutations such as those
listed in the single nucleotide polymorphism (SNP) data- Conclusions
base should be evaluated further, as a side chain trunca- Protein engineering studies have greatly increased our
tion that perturbs the stability even very little might trans- understanding of the mechanism and sequence deter-
form a monomeric protein into an obligate dimer or minants of domain swapping, in particular by providing
higher oligomer with impaired function. quantitative information. Modulation of the strain in the
Proteins may have evolved ways to protect against closed monomeric and more extended swapped hinge
the vulnerability that can arise from optimizing function. loop conformations appears to be a design strategy
One way is by compensatory mutations: for example, that is generally applicable. Mechanistic studies reveal
the first proline in the hinge loop of suc1 is conserved a picture of domain swapping that is intimately linked to
for the protein’s function, but it creates strain that makes the folding reaction. By making use of the same folding
the protein prone to domain swap; thus, as a balance, nucleus, a protein can fold as a monomer or as a domain-
the second proline appears to be required to prevent swapped oligomer. Higher order species could also as-
misfolding and aggregation, thus acting as a gatekeeper semble in a similar way and the open-ended domain-
for folding [35]. The second way is illustrated by the swapped state provides a generic, structural model for
observation that, while mutations can be made that in- the precursors in the formation of fibrillar diseased
crease suc1’s equilibrium domain swapping propensity states. Finally, the model of a strained loop as the main
by many orders of magnitude, the product of refolding driving force in domain swapping suggests that the phe-
of all of these mutant proteins is still overwhelming the nomenon could be a rather common side effect, as many
monomeric form (F. Rousseau et al., submitted). Thus, proteins are optimized for function at the cost of sta-
minimizing kinetic accessibility can limit the extent of bility.
domain swapping. Finally, the functional native state
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